Safety Alerts & Recalls

What does this mean?

Today's alert is a follow-up to other recent communications from the FDA on this issue. Most physicians will have already taken into account the increased risk of infection when balancing risks versus benefits of using this product. Most physicians screen for tuberculosis prior to starting ENBREL therapy.

That said, if you are taking ENBREL it is important to tell your doctor if you have previously suffered from tuberculosis or develop symptoms of a more serious infection - such as unplanned weight loss, night sweats, fever or productive cough that don't seem to get better.

New black box warning

Amgen and Wyeth Pharmaceuticals today notified healthcare professionals about changes to the prescribing information for ENBREL. These changes include a new black box warning relating to an increased risk of serious infections, and the importance of screening for tuberculosis in patients treated with ENBREL.

For more information, please visit: more information here

Source: Manufacturer
Publication Date: 2008-05-01
Last Updated: 2009-12-06

Visit the medication page for the following drugs:

Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download the MediGuard Mobile App to manage your prescription and over-the-counter medications, for free. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones.